SDMA: Diagnose kidney disease earlier
Earlier intervention for more effective management of canine and feline kidney disease
Over their lifetime, 1 in 3 cats1 and 1 in 10 dogs2 could develop chronic kidney disease (CKD)—a leading cause of death, particularly in cats. The IDEXX SDMA test* is a revolutionary new kidney function test that will enable veterinarians to diagnose CKD in cats and dogs months or even years earlier than traditional methods, making it possible to intervene earlier and more effectively manage kidney disease.
Investigate, Manage, and Monitor Kidney Disease Earlier with SDMA
SDMA is a methylated form of the amino acid arginine, which is produced in every cell and released into the body’s circulation during protein degradation. SDMA is excreted almost exclusively by the kidneys, making it a good marker for estimating kidney function. Research has shown that SDMA can identify CKD an average of 9 months earlier in dogs3 and 17 months sooner in cats—in one cat 4 years earlier.4 In addition, SDMA is not impacted by muscle mass, thereby providing practitioners a better tool for diagnosing and monitoring CKD in thin geriatric animals, especially cats and animals with other diseases that cause muscle wasting.5,6
NEW - Case Study: Kidney Disease Can Be Treated with Early Intervention
Scarlet - SDMA allows for early intervention to treat and impact early-stage kidney disease.
- NU-27 and NU-28
- NU-41 and NU-42
SDMA informational videos
What is SDMA?
The benefits of early diagnosis of CKD
Diagnosing CKD in underweight patients
IDEXX announces new SDMA test